Topic

Texas

A collection of 235 issues

Work With Your Doctor to Get Opdivo (Nivolumab) Covered by Blue Cross Blue Shield in Texas: Complete PA Guide and Appeal Process

Answer Box: Getting Opdivo Covered by Blue Cross Blue Shield in Texas Quick Path to Approval: Blue Cross Blue Shield of Texas requires prior authorization for Opdivo (nivolumab). Work closely with your oncologist to submit comprehensive documentation including diagnosis, staging, biomarker results, and prior therapy history. If denied, Texas law
6 min read

How to Get Spinraza (nusinersen) Covered by Aetna (CVS Health) in Texas: Complete Prior Authorization Guide with Appeal Scripts

Answer Box: Getting Spinraza Covered by Aetna in Texas Aetna (CVS Health) covers Spinraza (nusinersen) for spinal muscular atrophy but requires prior authorization with genetic confirmation, neurologist attestation, and baseline motor function scores. If denied, Texas patients have strong appeal rights with ~58% success rates when both internal appeals and
6 min read

How to Get Procysbi (Cysteamine Bitartrate DR) Covered by Cigna in Texas: Prior Authorization, Appeals, and Step Therapy Guide

Answer Box: Getting Procysbi Covered by Cigna in Texas Cigna requires prior authorization for Procysbi (cysteamine bitartrate delayed-release) and mandates step therapy with immediate-release cysteamine (Cystagon) first. To get coverage in Texas: (1) Document failed/intolerant trial of Cystagon, (2) Submit PA with genetic testing and WBC cystine levels, (3)
4 min read

How to Get Ibrance (Palbociclib) Covered by UnitedHealthcare in Texas: Prior Authorization Guide and Appeals Process

Answer Box: Getting Ibrance Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Ibrance (palbociclib) in Texas, with specific criteria for HR+/HER2- advanced breast cancer. The fastest path to approval: (1) Submit complete PA documentation showing HR+/HER2- diagnosis, intended combination with aromatase inhibitor or fulvestrant, and prior
6 min read

Renewing Cosentyx (Secukinumab) Approval with UnitedHealthcare in Texas: Documentation Guide & Timeline

Answer Box: Renewing Cosentyx with UnitedHealthcare in Texas UnitedHealthcare requires documented clinical response and specific therapy conditions for Cosentyx renewal in Texas. Submit renewal documentation 30-60 days before your current authorization expires. Key requirements: proof of positive clinical response (PASI/DLQI scores), confirmation you're not combining with other
5 min read